Fecal Microbiota Transplantation: A New Therapeutic Attempt from the Gut to the Brain.|https://dx.doi.org/10.1155/2021/6699268
Identification of patients at risk of Clostridioides difficile infection for enrollment in vaccine clinical trials.|https://dx.doi.org/10.1016/j.vaccine.2020.12.016
Investigational Treatment Agents for Recurrent Clostridioides difficile Infection (rCDI).|https://dx.doi.org/10.2147/JEP.S242959
Latent Class Analysis for the Diagnosis of Clostridioides difficile Infection.|https://dx.doi.org/10.1093/cid/ciaa1553
Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection With Greater Severity and Higher Recurrence Rates.|https://dx.doi.org/10.1093/cid/ciz009
Comparative genomics analysis of Clostridium difficile epidemic strain DH/NAP11/106.|https://dx.doi.org/10.1016/j.micinf.2018.01.004
Trends in incidence of long-term-care facility onset Clostridium difficile infections in 10 US geographic locations during 2011-2015.|https://dx.doi.org/10.1016/j.ajic.2017.11.026
Fecal Microbiota Transplantation and Its Usage in Neuropsychiatric Disorders.|https://dx.doi.org/10.9758/cpn.2016.14.3.231
